Quick Answer
UTAH MEDICAL PRODUCTS INC reported Research And Development Expense of $668.0 thousand for the year ending 2025.
- UTAH MEDICAL PRODUCTS INC showed a decrease of -17.8% in Research And Development Expense from 2024 to 2025.
- This data is from UTAH MEDICAL PRODUCTS INC's annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2011: $101.0 thousand | Q2 2011: $148.0 thousand | Q3 2011: $138.0 thousand | Q1 2012: $146.0 thousand | Q2 2012: $147.0 thousand | Q3 2012: $140.0 thousand | Q1 2013: $123.0 thousand | Q2 2013: $120.0 thousand | Q3 2013: $126.0 thousand | Q1 2014: $123.0 thousand | Q2 2014: $115.0 thousand | Q3 2014: $115.0 thousand | Q1 2015: $156.0 thousand | Q2 2015: $140.0 thousand | Q3 2015: $110.0 thousand | Q1 2016: $110.0 thousand | Q2 2016: $119.0 thousand | Q3 2016: $135.0 thousand | Q1 2017: $118.0 thousand | Q2 2017: $119.0 thousand | Q3 2017: $103.0 thousand | Q1 2018: $113.0 thousand | Q2 2018: $117.0 thousand | Q3 2018: $108.0 thousand | Q1 2019: $115.0 thousand | Q2 2019: $113.0 thousand | Q3 2019: $130.0 thousand | Q1 2020: $135.0 thousand | Q2 2020: $116.0 thousand | Q3 2020: $125.0 thousand | Q1 2021: $130.0 thousand | Q2 2021: $128.0 thousand | Q3 2021: $127.0 thousand | Q1 2022: $123.0 thousand | Q2 2022: $135.0 thousand | Q3 2022: $112.0 thousand | Q1 2023: $144.0 thousand | Q2 2023: $133.0 thousand | Q3 2023: $138.0 thousand | Q1 2024: $266.0 thousand | Q2 2024: $255.0 thousand | Q3 2024: $172.0 thousand | Q1 2025: $154.0 thousand | Q2 2025: $135.0 thousand | Q3 2025: $167.0 thousand.
- Over the full 17 years of available data (2009 to 2025), UTAH MEDICAL PRODUCTS INC's Research And Development Expense has grown by 85.0%.
- Historical annual values: Fiscal year 2025: $668.0 thousand | Fiscal year 2024: $813.0 thousand | Fiscal year 2023: $560.0 thousand | Fiscal year 2022: $493.0 thousand | Fiscal year 2021: $526.0 thousand | Fiscal year 2020: $486.0 thousand | Fiscal year 2019: $483.0 thousand | Fiscal year 2018: $454.0 thousand | Fiscal year 2017: $447.0 thousand | Fiscal year 2016: $475.0 thousand | Fiscal year 2015: $522.0 thousand | Fiscal year 2014: $460.0 thousand | Fiscal year 2013: $491.0 thousand | Fiscal year 2012: $563.0 thousand | Fiscal year 2011: -$518.0 thousand | Fiscal year 2010: $397.0 thousand | Fiscal year 2009: $361.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: